Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06029049 · ClinicalTrials.gov registry record · Phase 4

Comparison of Intubation Conditions During Rapid Sequence Induction Obtained With Modified Time Principal Induction With a Standard Intubation Dose of Rocuronium Versus Succinylcholine

A Phase 4 study of Anesthesia, sponsored by The University of Texas Health Science Center, Houston.

Recruiting
Registry status
Phase 4
Development phase
152
Enrollment target
1
Study location

NCT06029049 is a Phase 4 study of Anesthesia that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 152 participants, below the 109,408-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06029049, a Phase 4 study of Anesthesia, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.

RECRUITING
Registry status
Phase 4
Development phase
152 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess and compare conditions for tracheal intubation obtained with modified time principal induction with 0.6 mg/kg rocuronium and 1 mg/kg succinylcholine. Specifically, the investigators will be evaluating ease of laryngoscopy, vocal cord view, vocal cord opening, and movement of limbs and coughing during tracheal intubation in order to assess intubation conditions, to compare efficiency and success rate of tracheal intubation between two induction agents and to determine the rate of patient awareness during induction and post-operative recall of paralysis.

Conditions Studied

Interventions

  • DRUG Modified Time Principle Induction (MTPI) with rocuronium
  • DRUG RSI succinylcholine

Study Locations (1)

Texas

  • The University of Texas Health Science Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 152 participants
Start Date 2023-09-13
Est. Completion 2025-07-01
Phase Phase 4

What the Registry Record Tells You About NCT06029049

The ClinicalTrials.gov registry entry for NCT06029049 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 109,408-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anesthesia appearing as the primary indexed condition, and to 2 interventions - of which Modified Time Principle Induction (MTPI) with rocuronium is the first listed.

NCT06029049 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06029049 about?

NCT06029049 is a clinical study titled "Comparison of Intubation Conditions During Rapid Sequence Induction Obtained With Modified Time Principal Induction With a Standard Intubation Dose of Rocuronium Versus Succinylcholine". The purpose of this study is to assess and compare conditions for tracheal intubation obtained with modified time principal induction with 0.6 mg/kg rocuronium and 1 mg/kg succinylcholine. Specifically, the investigators will be evaluating ease of laryngoscopy, vocal cord view, vocal cord opening, a...

What is the current status of trial NCT06029049?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 152 participants. The study started on 2023-09-13. Estimated completion is 2025-07-01.

What conditions does trial NCT06029049 study?

This clinical trial studies the following conditions: Anesthesia.

What interventions are being tested in trial NCT06029049?

The interventions under investigation include: Modified Time Principle Induction (MTPI) with rocuronium (DRUG), RSI succinylcholine (DRUG).

Who is sponsoring clinical trial NCT06029049?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06029049 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anesthesia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.